Article
Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited.
Transfusion - 1 Apr 2024
Leiva-Torres Gabriel André, Cigna Maude, Constanzo-Yanez Jessica, St-Louis Maryse, Perreault Josée, Lavoie Josée, Laflamme Geneviève, Lewin Antoine, Pastore Yves, Robitaille Nancy
Abstract excerpt
BACKGROUND: Red blood cell transfusion is an effective treatment for patients with sickle cell disease (SCD). Alloimmunization can occur after a single transfusion, limiting further usage of blood transfusion. It is recommended to match for the ABO, D, C, E, and K antigens to reduce risks of alloimmunization. However, availability of compatible blood units can be challenging for blood providers with a limited...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
